4.3 Article

Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity

Chayanut Suwanpen et al.

JOURNAL OF NEPHROLOGY (2016)

Article Endocrinology & Metabolism

The alpha-lipoic acid decreases urinary podocalyxin excretion in type 2 diabetics by inhibiting oxidative stress in vivo

Haiyan Lin et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)

Article Endocrinology & Metabolism

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

Kenichi Sakamoto et al.

JOURNAL OF DIABETES RESEARCH (2015)

Article Endocrinology & Metabolism

Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia

Minoru Takemoto et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2013)

Article Medicine, General & Internal

Chronic kidney disease: global dimension and perspectives

Vivekanand Jha et al.

LANCET (2013)

Article Urology & Nephrology

Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy

Rin Asao et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Article Urology & Nephrology

The glomerular transcriptome and Proteome

Christer Betsholtz et al.

NEPHRON EXPERIMENTAL NEPHROLOGY (2007)

Review Urology & Nephrology

The spectrum of podocytopathies: A unifying view of glomerular diseases

R. C. Wiggins

KIDNEY INTERNATIONAL (2007)